SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882104-13-000028
Filing Date
2013-07-29
Accepted
2013-07-29 17:08:49
Documents
2
Period of Report
2013-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_137513211888636.html 3  
1 FORM 3 wf-form3_137513211888636.xml 3 1702
2 POWER OF ATTORNEY - DAVID MONTEZ a2013-07x_xxpdlxmontezsect.htm EX-24 3637
  Complete submission text file 0000882104-13-000028.txt   6782
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 932 SOUTHWOOD BLVD. INCLINE VILLAGE NV 89451
Business Address
Montez David (Reporting) CIK: 0001582712 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-19756 | Film No.: 13993251